Catalyst Wire Dossier Catalyst Wire Dossier

Nebivolol

Nebivolol · Ascend Laboratories, LLC
Drug timelines are a Plus or Pro feature.

80 regulatory and trial events tracked for Nebivolol, covering 2008-03-07 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy [Phase 3]

See pricing